Consolidated Balance Sheet

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7728785

Concept As at
2017-12-31
As at
2017-03-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
37,515,000,000 JPY
33,867,000,000 JPY
Notes and accounts receivable - trade
38,935,000,000 JPY
28,231,000,000 JPY
Securities
6,599,000,000 JPY
9,899,000,000 JPY
Merchandise and finished goods
7,156,000,000 JPY
8,004,000,000 JPY
Work in process
4,066,000,000 JPY
2,341,000,000 JPY
Raw materials and supplies
6,308,000,000 JPY
6,150,000,000 JPY
Other
2,291,000,000 JPY
2,000,000,000 JPY
Current assets
102,873,000,000 JPY
90,494,000,000 JPY
Non-current assets
46,937,000,000 JPY
44,565,000,000 JPY
Investments and other assets
20,328,000,000 JPY
17,921,000,000 JPY
Investment securities
19,053,000,000 JPY
15,943,000,000 JPY
Other
1,275,000,000 JPY
1,978,000,000 JPY
Non-current assets
Property, plant and equipment
26,181,000,000 JPY
26,271,000,000 JPY
Other, net
8,716,000,000 JPY
8,869,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
17,464,000,000 JPY
17,401,000,000 JPY
Own-used assets
Other
Intangible assets
Intangible assets
427,000,000 JPY
372,000,000 JPY
Investments and other assets
Assets
149,810,000,000 JPY
135,060,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
13,785,000,000 JPY
9,854,000,000 JPY
Short-term borrowings
3,875,000,000 JPY
3,875,000,000 JPY
Income taxes payable
3,055,000,000 JPY
3,049,000,000 JPY
Provisions
Provision for bonuses
592,000,000 JPY
1,271,000,000 JPY
Other
6,579,000,000 JPY
4,113,000,000 JPY
Current liabilities
30,368,000,000 JPY
24,020,000,000 JPY
Non-current liabilities
Retirement benefit liability
7,483,000,000 JPY
8,029,000,000 JPY
Other
354,000,000 JPY
355,000,000 JPY
Non-current liabilities
7,838,000,000 JPY
8,384,000,000 JPY
Liabilities
38,206,000,000 JPY
32,405,000,000 JPY
Liabilities and net assets
Shareholders' equity
107,105,000,000 JPY
99,778,000,000 JPY
Share capital
23,853,000,000 JPY
23,853,000,000 JPY
Capital surplus
11,408,000,000 JPY
11,407,000,000 JPY
Retained earnings
95,100,000,000 JPY
84,331,000,000 JPY
Treasury shares
-23,257,000,000 JPY
-19,813,000,000 JPY
Valuation and translation adjustments
4,498,000,000 JPY
2,876,000,000 JPY
Valuation difference on available-for-sale securities
5,900,000,000 JPY
4,611,000,000 JPY
Net assets
111,604,000,000 JPY
102,655,000,000 JPY
Liabilities and net assets
149,810,000,000 JPY
135,060,000,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments
Remeasurements of defined benefit plans
-1,401,000,000 JPY
-1,734,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.